Biotechnology
Gracell Expands Executive Team by Appointment of CMO Dr. Martina Sersch and CFO Dr. Kevin Xie
SHANGHAI and SUZHOU, China, July 23, 2020 /PRNewswire/ -- Internationally renowned clinical-stage immune cell and gene therapy company, Gracell Biotechnologies Co., Ltd. ("Gracell" or "the Company") has announced two appointments to the executive suite. Chief Medical Officer Dr.Martina Sersch, M...
2020-07-23 22:00
2544
Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test
SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...
2020-07-21 23:00
1857
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum
SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...
2020-07-21 22:04
2149
Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales
INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announced today strong financial results for its fiscal 2020 second
quarter endingJune 30, 2020, maintaining steady business performance with a
high operating margin at 26.4%.
2020-07-21 20:20
16599
PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit
GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...
2020-07-20 21:00
1842
Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner
SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...
2020-07-15 07:00
14246
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology
Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...
2020-07-14 09:30
2644
NTHU Research Team Develops a Rapid Test Kit for Potential Severe Covid-19 Cases
HSINCHU, July 13, 2020 /PRNewswire/ -- Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more effici...
2020-07-14 01:00
1176
Samsung Biologics signs additional development and manufacturing agreement with STCube
SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate. STM418 received much attention from the biopha...
2020-07-12 08:00
1523
WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia
SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...
2020-07-09 16:32
1447
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States
DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO). A patent...
2020-07-08 01:00
1234
A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer
WUHAN, China, July 7, 2020 /PRNewswire/ -- Hubei Soundny Biotechnology ("Soundny" or the "Company"), a leading biotechnology company dedicated to developing cancer treatments, has announced the publication of its latest findings on cholangiocarcinoma in Nature Biomedical Engineering, a Nature pu...
2020-07-07 13:25
987
New strategic partnership to develop next-generation T cell detection reagents
SHANGHAI, China and COPENHAGEN, Denmark, July 2, 2020 /PRNewswire/ -- Today two MedTech companies, Polaris Biology ofChina and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commerciali...
2020-07-02 21:00
1208
Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US
SUZHOU, China, July 1, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfull...
2020-07-01 23:00
989
Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system
TOKYO, July 1, 2020 /PRNewswire/ -- Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system. Hitachi provides a broad range of s...
2020-07-01 22:00
6198
Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA
TAIPEI, July 1, 2020 /PRNewswire/ -- Golden Biotechnology Corp. (GoldenBiotech, 4132.TWO), a leading Taiwanese biopharmaceutical company, announced that the FDA approved its investigational new drug (IND) application for a Phase II clinical trial of Antroquinonol (Hocena®) on COVID-19 patients in...
2020-07-01 18:36
2580
Immvira Announces the Appointment of Carl Yeung as Chief Financial Officer
SHENZHEN, China, June 30, 2020 /PRNewswire/ -- Today Immvira Group Company (Immvira or the "Company"), a biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, announces the appointment ofCarl Yeung as Chief Financial Officer, report...
2020-07-01 08:30
1825
'Curing Cancer without Surgery'
* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer drug, Polytaxel, without side effects such as weight loss." * Suppressed 99.8% of tumors despite a non-toxic dose…more effective than existing FDA-approved pancreatic cancer drugs. * Hopes for a Kore...
2020-06-30 15:10
1303
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction
BEIJING, June 29, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that the Company disagrees with the notice delivered by Xinjiang Deyuan Bioeng...
2020-06-29 13:00
11666
PharmAbcine Signs Long-term Contract Manufacturing Organization Agreement for Olinvacimab with Binex
DAEJEON, South Korea, June 26, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340) (CEO: Jin-san Yoo), biotech company focusing on the development of antibody therapeutics, announced on 18th that it had signed a contract manufacturing organization(CMO) agreement with biologics contract development ...
2020-06-27 00:00
1639
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 318 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 288 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 253 media titles]
2024-04-30 15:13Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
12314
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
7944
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7544
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
7480
